Citadel Advisors’s SurgePays SURG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30K Buy
+83,163
New +$46K ﹤0.01% 13301
2025
Q1
Sell
-41,486
Closed -$61.2K 15530
2024
Q4
$73.8K Buy
+41,486
New +$73.1K ﹤0.01% 11890
2024
Q2
Sell
-3,558
Closed -$13.4K 15361
2024
Q1
$13.7K Buy
+3,558
New +$23.7K ﹤0.01% 13285
2023
Q4
Sell
-1,129
Closed -$6.01K 15226
2023
Q3
$5.28K Sell
1,129
-12,045
-91% -$62.5K ﹤0.01% 13411
2023
Q2
$96.3K Buy
+13,174
New +$78.5K ﹤0.01% 11001
2022
Q1
Sell
-13,584
Closed -$27K 14542
2021
Q4
$27K Buy
+13,584
New +$34.8K ﹤0.01% 13508

Other funds holding SURG

Citadel Advisors's SURG Position: Q2 2026 in Review

Citadel Advisors opened a new position in SurgePays (SURG) in Q2 2026: 83,163 shares worth $30K. The stake represents ﹤0.01% of the portfolio and ranks #13301 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in SURG as recently as Q4 2024.

Citadel Advisors first reported a position in SURG in Q4 2021 and has held it in 6 quarters since. The position peaked at $96.3K in Q2 2023. 36 funds tracked by Wall St. Rank hold SURG as of Q2 2026.

  • Citadel Advisors held 83,163 shares of SurgePays worth $30K as of Q2 2026.
  • SurgePays was a new Citadel Advisors position in Q2 2026.
  • SurgePays made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13301 holding.
  • Citadel Advisors first reported a position in SurgePays in Q4 2021 and has held it in 6 quarters since.
  • Citadel Advisors's SurgePays position peaked at $96.3K in Q2 2023.
  • 36 funds tracked by Wall St. Rank held SurgePays as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.